Which is a clinical manifestation of diabetes insipidus?

Reasoning:

Choice A reason: Acknowledging the client’s relief does not educate them about the TIA’s significance. TIAs indicate transient cerebral ischemia, increasing stroke risk, but this response fails to address the need for risk modification, missing an opportunity to promote preventive measures critical for stroke prevention.

Choice B reason: Stating that TIA symptoms resolve within 24 hours is factually correct but does not emphasize the serious nature of TIAs as stroke precursors. Without addressing risk reduction, this response fails to educate the client on the need for lifestyle changes or medical intervention to prevent future events.

Choice C reason: Saying all TIA patients will develop a stroke is inaccurate, as not all progress to stroke. TIAs significantly increase stroke risk, but many can be prevented with proper management. This response is overly fatalistic and does not encourage proactive risk reduction strategies.

Choice D reason: Explaining that a TIA is a warning sign and discussing risk reduction educates the client about its significance as a transient cerebral ischemia event, increasing stroke risk. This response promotes lifestyle changes, medication adherence, and medical follow-up, empowering the client to prevent future strokes effectively.

Reasoning:

Choice A reason: Weakness is a general symptom in sickle cell disease due to chronic anemia and reduced oxygen delivery but is not specific to liver complications. Weakness results from systemic hypoxia or energy depletion, not localized hepatic vaso-occlusion or damage, making it less indicative.

Choice B reason: Fatigue is common in sickle cell disease due to chronic hemolysis and anemia but does not specifically indicate liver complications. It reflects reduced red blood cell oxygen-carrying capacity, not hepatic involvement, which requires more localized signs like pain to confirm organ-specific issues.

Choice C reason: Glucose intolerance is not a typical liver complication in sickle cell disease. While chronic disease may affect metabolism, liver complications in SCD involve vaso-occlusion or iron overload, not direct glucose regulation issues, making this finding less relevant to hepatic involvement in this context.

Choice D reason: Abdominal pain, particularly in the right upper quadrant, indicates a liver complication in sickle cell disease. Vaso-occlusion in hepatic vessels or iron overload from transfusions can cause hepatic ischemia or hepatomegaly, leading to pain, a specific sign of liver involvement in SCD exacerbations.